+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study



Low-dose dobutamine test associated with interventricular dyssynchrony: a useful tool to identify cardiac resynchronization therapy responders: data from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) phase 2 study



American Heart Journal 163(3): 422-429



Cardiac resynchronization therapy (CRT) is effective in patients with heart failure, but 3% to 5% of subjects are classified as nonresponders. Identifying responders remains a challenging task. The LODO-CRT trial investigated the association between left ventricular contractile reserve (LVCR) and clinical and echocardiographic long-term CRT response. This is a multicenter, prospective, observational study. Left ventricular contractile reserve was detected using a dobutamine stress echocardiography test, defined as an ejection fraction increase of >5 points. Clinical CRT response was defined as the absence of major cardiovascular events (ie, cardiovascular death or heart failure hospitalization). Echocardiographic response was defined as a left ventricle end-systolic volume reduction of >1%. A total of 221 CRT-indicated patients were studied (8% presented LVCR). During a mean follow-up of 15 5 months, 17 patients died and 16 were hospitalized due to heart failure. The proportion of clinical responders was 155 (88%) of 177 and 33 (75%) of 44 (P = .36) in the groups with and without LVCR, respectively. Kaplan-Meier analysis showed a significant difference in cardiac survival/hospitalization between patients with and without LVCR. The proportion of echocardiographic responders was 144 (87%) of 166 and 16 (42%) of 38 in the groups with and without LVCR (P < .1), respectively; LVCR showed 9% sensitivity and 87% positive predictive value to prefigure echocardiographic CRT responders. Multivariable analysis identified LVCR and interventricular dyssynchrony as independent predictors of CRT response. The concomitant presence of both factors showed 99% specificity and 83% sensitivity in detecting responders. The presence of LVCR helps in predicting a clinical and echocardiographic CRT response. Concomitant assessment of LVCR and interventricular dyssynchrony accurately stratifies responder and nonresponder patients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036355159

Download citation: RISBibTeXText

PMID: 22424013

DOI: 10.1016/j.ahj.2011.11.015


Related references

Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy--results from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) trial. Heart Rhythm 7(11): 1600-1605, 2011

Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapyresults from the Low dose Dobutamine Stress-Echo Test in Cardiac Resynchronization Therapy (Lodo-Crt) Trial. Yearbook of Cardiology 2011: 306-309, 2011

Low-dose dobutamine stress echocardiography to assess left ventricular contractile reserve for cardiac resynchronization therapy: data from the Low-Dose Dobutamine Stress Echocardiography to Predict Cardiac Resynchronization Therapy Response (LODO-CRT) trial. Congestive Heart Failure 16(3): 104-110, 2011

Can changes in intra-ventricular dyssynchrony during low dose dobutamine stress echo quantify degree of response to cardiac resynchronization therapy?. 2007

Low-dose dobutamine stress echo to quantify the degree of remodelling after cardiac resynchronization therapy. European Heart Journal 30(8): 950-958, 2009

Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: design and rationale. American Heart Journal 156(4): 656-661, 2008

Contractile reserve assessed by dobutamine test identifies super-responders to cardiac resynchronization therapy. Archives of Medical Science 10(4): 684-691, 2014

Presence of left ventricular contractile reserve, evaluated by means of dobutamine stress-echo test, is able to predict response to cardiac resynchronization therapy. Journal of Interventional Cardiac Electrophysiology 23(2): 121-126, 2008

Low-dose dobutamine stress echo for reverse remodeling prediction after cardiac resynchronization. Advances in Medical Sciences 60(2): 294-299, 2016

Usefulness of low-dose dobutamine echocardiography to predict response and outcome in patients undergoing cardiac resynchronization therapy. American Journal of Cardiology 108(2): 252-257, 2011

Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry. Europace 15(9): 1273-1279, 2014

Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is useful before cardiac resynchronization therapy if QRS duration is available. Circulation. Cardiovascular Imaging 1(1): 79-84; Discussion 84, 2009

Is echocardiographic assessment of dyssynchrony useful to select candidates for cardiac resynchronization therapy? Echocardiography is not useful before cardiac resynchronization therapy if QRS duration is available. Circulation. Cardiovascular Imaging 1(1): 70-7; Discussion 78, 2009

Low-dose dobutamine echo stress test for the evaluation of cardiac function in asymptomatic childhood cancer survivors treated years before with anthracycline. European Heart Journal 19(ABST SUPPL ): 312, 1998

Cardiac resynchronization therapy outcomes in patients with chronic heart failure: cardiac resynchronization therapy with pacemaker versus cardiac resynchronization therapy with defibrillator. Journal of Cardiovascular Medicine 18(12): 962-967, 2017